ansuvimab: Clinical Trials

1 trial of ansuvimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow ansuvimab: new trials by email Literature Review of ansuvimab trials Research Report on ansuvimab

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults
VRC-EBOMAB092-00-AB (MAb114) - Healthy Adult Immune Responses to Vaccine
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)192018-05-162020-10-26

Conditions studied

Hemorrhagic Fever, Ebola (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (1)

Top investigators

Martin R Gaudinski, M.D. (1)

Results publications

PMID 30686586